Piper Sandler lowered the firm’s price target on Tempus AI (TEM) to $55 from $70 following quarterly results. The firm keeps a Neutral rating ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...

Cathie Wood‘s Ark Invest executed significant trades involving Airbnb Inc. (NASDAQ:ABNB), Coinbase Global Inc. (NASDAQ:COIN), ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI (NASDAQ:TEM) as the stock took a 15% ...

Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...

Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...